newsfilter
← Latest News
Business Wire·

Cortexyme to Present at Annual Biomarkers for Alzheimer's Disease Summit

Cortexyme, Inc. (NASDAQ:CRTX), a company advancing a pivotal trial in Alzheimer's disease with top-line data expected by mid-November 2021 and a growing pipeline of therapeutics for degenerative diseases, will participate as a featured speaker covering